Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Melanoma × Cyclophosphamide × Clear all

Phase

Phase 1 44 Phase 2 40 Phase 1/2 28 Phase NA 2 Phase EARLY_PHASE1 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 127 Lymphoma 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 44 Lymphoma, Large B-Cell, Diffuse 39 Leukemia 39 Lymphoma, Follicular 33 Lymphoma, Non-Hodgkin 31 Multiple Myeloma 29 Leukemia, Lymphocytic, Chronic, B-Cell 25 Leukemia, Myeloid, Acute 22 Burkitt Lymphoma 21 Neuroblastoma 17 Hodgkin Disease 15 Lymphoma, Large-Cell, Immunoblastic 14 Neoplasms 11 Lymphoma, Mantle-Cell 11 Lymphoma, B-Cell, Marginal Zone 9 Triple Negative Breast Neoplasms 8 Sarcoma 8 Neoplasms, Plasma Cell 8 Myelodysplastic Syndromes 8 Inflammatory Breast Neoplasms 8 Graft vs Host Disease 8 Rhabdomyosarcoma 7 Recurrence 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Lung Neoplasms 6 Lymphoma, T-Cell, Peripheral 5 Lymphoma, Large-Cell, Anaplastic 5 Leukemia, Erythroblastic, Acute 5

Interventions

Dacarbazine 22 Nivolumab 20 pembrolizumab 15 Ipilimumab 15 Interferon-alpha 10 trametinib 7 aldesleukin 7 dabrafenib 6 Vemurafenib 6 Temozolomide 6 Introns 6 Interferon alpha-2 6 Interleukin-2 5 Cisplatin 5 Radiotherapy 4 Chemotherapy, Adjuvant 4 cobimetinib 3 cemiplimab 3 binimetinib 3 Vinblastine 3 Specimen Handling 3 Sodium Chloride 3 Radiosurgery 3 Paclitaxel 3 Opdualag 3 Melphalan 3 Magnetic Resonance Spectroscopy 3 CTLA-4 Antigen 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 spartalizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02278887 2025-03-10

TIL

The Netherlands Cancer Institute

Phase 3 Completed

Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡